Biora Therapeutics Inc Cash Flow-to-Debt Ratio
Biora Therapeutics Inc cash flow-to-debt ratio. Biora Therapeutics Inc (BIOR) has a Cash Flow-to-Debt Ratio of -0.07x as of September 2024, meaning its operating cash flow of $-8.73 Million could theoretically repay 0% of its total liabilities ($121.13 Million) in one year. Check BIOR operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biora Therapeutics Inc (2018–2023)
Cash flow-to-debt ratio of Biora Therapeutics Inc from 2018 to 2023. Historical debt coverage capacity for Biora Therapeutics Inc across 6 annual periods. Also explore how fast is Biora Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Biora Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2018–2023)
Biora Therapeutics Inc cash flow-to-debt ratio by year from 2018 to 2023. Year-by-year debt coverage analysis for Biora Therapeutics Inc. For the full cash flow conversion analysis, see Biora Therapeutics Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.37x | $-48.50 Million | $132.64 Million | ▲ +11.6% |
| 2022 | -0.41x | $-64.42 Million | $155.81 Million | ▲ +52.2% |
| 2021 | -0.86x | $-167.49 Million | $193.81 Million | ▼ -36.3% |
| 2020 | -0.63x | $-165.74 Million | $261.43 Million | ▼ -10.9% |
| 2019 | -0.57x | $-106.12 Million | $185.60 Million | ▼ -34.6% |
| 2018 | -0.42x | $-65.13 Million | $153.37 Million | — |